Overweight

• FDA label_change · 2024-12-20
  FDA Approved: ZEPBOUND — Supplemental Application (Eli Lilly and Company)

  FDA approves a supplemental application for ZEPBOUND (tirzepatide) from Eli Lilly to update the drug's labeling related to weight management…